Gilead Sciences reported $10.21B in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 383.44M 17.6M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Amgen AMGN:US $ 14585M 1716M
Arena Pharmaceuticals ARNA:US $ 64.84M 17.33M
Biogen BIIB:US $ 3347.2M 181.4M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Coherus Biosciences CHRS:US $ 287.05M 29.45M
Eli Lilly And LLY:US $ 15093.2M 3379M
Gilead Sciences GILD:US $ 10214M 509M
Glaxosmithkline GSK:US $ 21387M 1112M
GlaxoSmithKline GSK:LN 21387M 1112M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Moderna Inc MRNA:US 8.84B 399M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NOVN:VX SF 29633M 527M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Puma Biotechnology PBYI:US $ 137.9M 2.51M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
United Therapeutics UTHR:US $ 311.4M 9M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
YTE INCY:US $ 660.32M 36.44M